Latest Articles

Publication Date
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com

Published: March 5, 2025, 11:04 a.m.
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - Oncology Nurse Advisor

Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer Oncology Nurse Advisor

Published: March 5, 2025, 5 a.m.
Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer - Frontiers

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer Frontiers

Published: March 4, 2025, 1:24 p.m.
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - BioMed Central

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis BioMed Central

Published: Feb. 28, 2025, 10:47 a.m.
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - bmcwomenshealth.biomedcentral.com

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis bmcwomenshealth.biomedcentral.com

Published: Feb. 28, 2025, 10:47 a.m.
Short-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effective - MSN

Short-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effective MSN

Published: Feb. 24, 2025, 4:36 a.m.
Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer - OncLive

Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer OncLive

Published: Feb. 21, 2025, 9:57 p.m.
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - Physician's Weekly

Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer Physician's Weekly

Published: Feb. 21, 2025, 6:31 a.m.
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - Diabetes In Control

Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer Diabetes In Control

Published: Feb. 20, 2025, 7:52 p.m.
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - HealthDay

Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer HealthDay

Published: Feb. 20, 2025, 4:55 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!